Outcomes of endovascular aneurysm repair in patients with hostile neck anatomy

Tools

Stather, P. W. ORCID: https://orcid.org/0000-0002-3585-6728, Sayers, R. D., Cheah, A., Wild, J. B., Bown, M. J. and Choke, E. (2012) Outcomes of endovascular aneurysm repair in patients with hostile neck anatomy. European Journal of Vascular and Endovascular Surgery, 44 (6). pp. 556-561. ISSN 1078-5884

Full text not available from this repository. (Request a copy)

Abstract

Objectives: This study aims to evaluate outcomes following EVAR in patients with hostile neck anatomy (HNA). Methods: Data prospectively collected from 552 elective EVARs were analysed retrospectively. Data regarding neck morphology was obtained from aneurysm stent plans produced prior to EVAR. HNA was defined as any of; neck diameter >28 mm, neck angulation >60°, neck length <15 mm, neck thrombus, or neck flare. Results: 552 patients underwent EVAR. Mean age 73.9 years, mean follow-up 4.1 years. 199 patients had HNA, 353 had favourable neck anatomy (FNA). There was a significant increase in late type I endoleaks (FNA 4.5%, HNA 9.5%; P = 0.02) and total reinterventions (FNA 11.0%, HNA 22.8%; P < 0.01), and a significant decrease in late type II endoleaks in patients with HNA (FNA 16.7%, HNA 10.6%; P < 0.05). There was no significant difference in technical success (FNA 0.6%, HNA 2.0%; p = 0.12), 30-day re-intervention (FNA 2.8%, HNA 5.0%; P = 0.12), 30-day mortality (FNA 1.1%, HNA 0.5%; P = 0.45), 30-day type I endoleaks (FNA 0.8%, HNA 2.5%; P = 0.12), 5-year mortality (FNA 15.1%, HNA 14.6%; P = 0.86), aneurysm-related mortality (FNA 1.7% versus HNA 2.0%; P = 0.79), stent-graft migration (FNA 2.5%, HNA 3.0%; P = 0.75), sac expansion (FNA 13.0%, HNA 9.5%; P = 0.22), or graft rupture (FNA 1.1%, HNA 3.5%; P = 0.05). Binary logistic regression of individual features of HNA revealed secondary intervention (P = 0.009), technical failure (P = 0.02), and late type I endoleaks (P = 0.002), were significantly increased with increased neck diameter. Conclusions: HNA AAAs can be successfully treated with EVAR. However, surveillance is necessary to detect and treat late type I endoleaks in HNA patients.

Item Type: Article
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 02 May 2023 14:30
Last Modified: 09 May 2023 09:30
URI: https://ueaeprints.uea.ac.uk/id/eprint/91931
DOI: 10.1016/j.ejvs.2012.10.003

Actions (login required)

View Item View Item